We are live on ! Find out more
CERE

Cerevel Therapeutics Holdings, Inc. Common Stock
CERE

Delisted

CERE was delisted on the 31st of July, 2024.

Back to rankings

0 hedge funds and large institutions have $0 invested in Cerevel Therapeutics Holdings, Inc. Common Stock in 2024 Q4 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 2 → 0 (-2)

100% less capital invested

Capital invested by funds: $20.7K → $0 (-$20.7K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 2

Holders
–
Holders Change
-2
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

1
IA
IFP Advisors
Florida
-$15.5K
2
BTI
Blue Trust Inc
Georgia
-$5.15K
Name Holding Trade Value Shares
Change 		Change in
Stake
IA
1
IFP Advisors
Florida
– -$15.5K -346 Closed
BTI
2
Blue Trust Inc
Georgia
– -$5.15K -126 Closed

CERE Hedge Fund Activity: Q4 2024 in Review

0 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) for Q4 2024, worth a combined $0 — down 100% from $20.7K a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of CERE and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was IFP Advisors, exiting entirely with an estimated $15.5K sold.

  • 0 institutional investors held Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) as of Q4 2024, down from 2 in Q3 2024.
  • Funds reported $0 of Cerevel Therapeutics Holdings, Inc. Common Stock stock for Q4 2024, down 100% quarter-over-quarter.
  • 0 funds opened new Cerevel Therapeutics Holdings, Inc. Common Stock positions in Q4 2024 and 2 closed out, a net change of -2 holders.
  • The largest Cerevel Therapeutics Holdings, Inc. Common Stock seller in Q4 2024 was IFP Advisors, an estimated $15.5K sold.

Based on aggregated 13F filings for Q4 2024.